• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Common Sensing, Welkin Health collaborate on digital diabetes management system

February 21, 2017 By Sarah Faulkner

Common SensingCommon Sensing, Welkin Health collaborate on digital diabetes management system and Welkin Health said last month that the companies are partnering to develop a digital diabetes management program designed to improve insulin adherence.

The companies plan to craft a program that combines insulin dosing data collected from Common Sensing’s Gocap smart insulin pen with Welkin Health’s digital coaches to support patients with diabetes.

The Gocap device is designed to collect and monitor patients’ insulin doses, according to co-founder & president James White.

“We are the 1st company that is monitoring and delivering home insulin use support in a scalable way,” he said in an interview with Medgadget.

“The program we’re developing with Welkin will provide a critical element that is missing from home insulin delivery—a human touch,” White said in prepared remarks. “If an individual is taking the wrong amount of insulin or misses an insulin dose, they will be contacted immediately by a Certified Diabetes Educator (CDE) who can work with the user to resolve the issue. Data-driven, real-time intervention from coaches will set insulin users up for success between doctor visits, improving the health of people living with diabetes.”

Researchers estimate that more than 60% of patients beginning insulin therapy stop within the first 3 months, according to Welkin Health. The companies anticipate that their platform will identify triggers, including a drop in glucose levels or a missed dose, and prompt a CDE to provide real-time feedback and advice to the patient.

“Adherence challenges continue to be an issue for people managing diabetes, yet, research shows, individuals who receive health coaching are likely to be more consistent and adherent to medication,” Welkin Health CEO & co-founder Chase Hensel added. “If a patient stops taking their insulin or misses a dose, there’s a reason for that—we want to understand why. The real-time data that care teams will receive through our program, as well as the ability to react swiftly when prompted, will afford more opportunities to keep patients on track with insulin regimens and we believe, vastly improve insulin adherence and overall health outcomes.”

Filed Under: Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Wall Street Beat Tagged With: Common Sensing, Welkin Health

IN CASE YOU MISSED IT

  • MedAlliance wins second FDA IDE nod for drug-coated balloon
  • Wells Fargo downgrades Tandem amid rise of automated insulin delivery competition
  • FDA approves first targeted infusion therapy for HER2-low breast cancer
  • Abbott, WeightWatchers partner on diabetes care
  • Insulet up on Q2 sales beat, raised full-year guidance

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS